( en | de | ru )

 

Disambiguierung von "Schmitz, Norbert"

Autor der Publikation

KopierenLöschenDiese Publikation zur Ablage hinzufügen
Long-term outcome and late effects in patients transplanted with mobilised blood or bone marrow: a randomised trial

, , , , , , , , , und . The Lancet Oncology, 11 (4): 331–338 (2010)

Bitte wählen Sie eine Person um die Publikation zuzuordnen

Um zwischen Personen mit demselben Namen zu unterscheiden, wird der akademische Grad und der Titel einer wichtigen Publikation angezeigt. Zudem lassen sich über den Button neben dem Namen einige der Person bereits zugeordnete Publikationen anzeigen.

Norbert Schmitz

Norbert Schmitz

Norbert Schmitz

Norbert Schmitz

Norbert Schmitz

 

Weitere Publikationen von Autoren mit dem selben Namen

Perceived needs for and use of workplace accommodations by individuals with a depressive and/or anxiety disorder, , , , und . Journal of Occupational and Environmental Medicine, 53 (11): 1268-1272 (November 2011)CNS events in elderly patients with aggressive lymphoma treated with modern chemotherapy (CHOP-14) with or without rituximab: an analysis of patients treated in the RICOVER-60 trial of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL), , , , und . Blood, 113 (17): 3896–3902 (2009)Response: Intrathecal methotrexate and central nervous system events, , , und . Blood, 114 (9): 1999–2000 (2009)MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma, , , , , , , , , und 10 andere Autor(en). Blood, 121 (12): 2253–2263 (2013)International Consensus Conference on High-Dose Therapy with Hematopoietic Stem Cell Transplantation in Aggressive Non-Hodgkin's Lymphomas: report of the jury, , , , , , , , , und 4 andere Autor(en). Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 17 (1): 423–429 (1999)CHO(E)P-14 followed by alemtuzumab consolidation in untreated peripheral T cell lymphomas: final analysis of a prospective phase II trial, , , , , , , , , und . Annals of hematology, 92 (11): 1521–1528 (2013)Incidence and risk factors of central nervous system recurrence in aggressive lymphoma--a survey of 1693 patients treated in protocols of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL), , , , , , und . Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, 18 (1): 149–157 (2007)High-dose therapy followed by autologous stem-cell transplantation with and without rituximab for primary treatment of high-risk diffuse large B-cell lymphoma, , , , , , , , , und . Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, 21 (11): 2255–2261 (2010)High-dose CHOP plus etoposide (MegaCHOEP) in T-cell lymphoma: a comparative analysis of patients treated within trials of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL), , , , , , , , und . Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, 20 (12): 1977–1984 (2009)Spieltheorie, , und . Teubner Studienbücher Teubner, Stuttgart, (1979)